In this podcast, Dan Fisher, managing director for IPM.ai, a division of Real Chemistry, explains how real world health data generated from more than 300 million de-identified patient records can help brands predict and assess a patient population, accelerate clinical trial recruitment, and optimize commercial outcomes.Machine learning and artificial intelligence have emerged as key technologies […]
